Current:Home > BackDrugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations-DB Wealth Institute B2 Expert Reviews
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations
View Date:2024-12-23 19:17:43
The Biden administration says Medicare recipients will save about $1.5 billion on out-of-pocket costs for medications to treat diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026.
The savings range from 79% for Januvia, used to manage diabetes, to 38% for Imbruvica, which is used to treat blood cancers. That is the medication’s cost before any discounts or rebates are applied, but not what the price people actually pay when filling their prescriptions.
A look at the drugs and the negotiated prices.
Januvia
Manufacturer: Merck Sharp Dohme
Conditions: Diabetes
Negotiated price: $113 for a 30-day supply
Reduction: 79%
Fiasp; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill:
Manufacturer: Novo Norodisk
Conditions: Diabetes
Negotiated price: $119 for a 30- day supply
Reduction: 76%
Farxiga
Manufacturer: AstraZeneca AB.
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $178.50 for a 30-day supply
Reduction: 68%
Enbrel
Manufacturer: Immunex Corp.
Conditions: Rheumatoid arthritis, psoriasis and psoriatic arthritis
Negotiated price: $2,355 for a 30-day supply
Reduction: 67%
Jardiance
Manufacturer: Boehringer Ingelheim
Conditions: Diabetes, heart failure and chronic kidney disease
Negotiated price: $197 for a 30-day supply
Reduction: 66%
Stelara
Manufacturer: Janssen Biotech Inc.
Conditions: Psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis
Negotiated price: $4,695 for a 30-day supply
Reduction: 66%
Xarelto
Manufacturer: Janssen Pharms
Conditions: Prevention and treatment of blood clots. Reduction of risk for patients with coronary or peripheral artery disease
Negotiated price: $197 for a 30-day supply
Reduction: 62%
Eliquis
Manufacturer: Bristol Myers Squibb
Conditions: Prevention and treatment of blood clots
Negotiated price: $231 for a 30-day supply
Reduction: 56%
Entresto
Manufacturer: Novartis Pharms Corp
Conditions: Heart failure
Negotiated price: $295 for a 30-day supply
Reduction: 53%
Imbruvica
Manufacturer: Pharmacyclics LLC
Conditions: Blood cancers
Negotiated price: $9,319 for a 30-day supply
Savings: 38%
veryGood! (51)
Related
- Lululemon, Disney partner for 34-piece collection and campaign: 'A dream collaboration'
- Site of 3 killings during 1967 Detroit riot to receive historic marker
- Oregon wildfire map: Track 38 uncontrolled blazes that have burned nearly 1 million acres
- LeBron James flag bearer: Full (sometimes controversial) history of Team USA Olympic honor
- Powerball winning numbers for November 11 drawing: Jackpot hits $103 million
- Last week's CrowdStrike outage was bad. The sun has something worse planned.
- French rail system crippled before start of Olympics: See where attacks occurred
- Three men — including ex-Marines — sentenced for involvement in plot to destroy power grid
- Federal judge orders Oakland airport to stop using ‘San Francisco’ in name amid lawsuit
- Arkansas standoff ends with suspect dead after exchange of gunfire with law enforcement
Ranking
- Taylor Swift gifts 7-year-old '22' hat after promising to meet her when she was a baby
- TikToker Chris Olsen Tearfully Shares He’s a Victim of Revenge Porn
- 270 flights canceled in Frankfurt as environmental activists target airports across Europe
- California Gov. Gavin Newsom orders sweep of homeless encampments
- Record-setting dry conditions threaten more US wildfires, drinking water supplies
- Deadpool & Wolverine Seemingly Pokes Fun at Jennifer Garner and Ben Affleck's Divorce
- Sammy Hagar 'keeping alive' music of Van Halen in summer Best of All Worlds tour
- Elon Musk’s Ex Grimes Shares Support for His Daughter Vivian After Comments on Gender Identity
Recommendation
-
Anti-abortion advocates press Trump for more restrictions as abortion pill sales spike
-
Water Polo's official hype man Flavor Flav wants to see women win fourth gold
-
2024 Paris Olympics: You'll Want to Stand and Cheer for These Candid Photos
-
Oprah Winfrey and Gayle King Address Longstanding Rumors They’re in a Relationship
-
Oregon's Dan Lanning, Indiana's Curt Cignetti pocket big bonuses after Week 11 wins
-
Justin Timberlake’s lawyer says pop singer wasn’t intoxicated, argues DUI charges should be dropped
-
Rain could dampen excitement of Paris Olympics opening ceremony
-
Bills co-owner Kim Pegula breaks team huddle in latest sign of her recovery from cardiac arrest